Search by Drug Name or NDC
NDC 60505-6098-01 Tigecycline 50 mg/5mL Details
Tigecycline 50 mg/5mL
Tigecycline is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Apotex Corp. The primary component is TIGECYCLINE.
MedlinePlus Drug Summary
Tigecycline injection used to treat certain serious infections including community acquired pneumonia (a lung infection that developed in a person who was not in the hospital), skin infections, and infections of the abdomen (area between the chest and the waist). Tigecycline injection should not be used to treat pneumonia that developed in people who are on ventilators or who were in a hospital or foot infections in people who have diabetes. Tigecycline injection is in a class of medications called tetracycline antibiotics. It works by killing bacteria that cause infection. Antibiotics such as tigecycline injection will not work for colds, flu, or other viral infections. Using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.
Related Packages: 60505-6098-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Tigecycline Injection
Product Information
| NDC | 60505-6098 |
|---|---|
| Product ID | 60505-6098_e0e9a483-52c4-16dd-6a44-71c5af5fd80c |
| Associated GPIs | 04350070002120 |
| GCN Sequence Number | 059270 |
| GCN Sequence Number Description | tigecycline VIAL 50 MG INTRAVEN |
| HIC3 | W9D |
| HIC3 Description | GLYCYLCYCLINES |
| GCN | 24855 |
| HICL Sequence Number | 032986 |
| HICL Sequence Number Description | TIGECYCLINE |
| Brand/Generic | Generic |
| Proprietary Name | Tigecycline |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | TIGECYCLINE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 50 |
| Active Ingredient Units | mg/5mL |
| Substance Name | TIGECYCLINE |
| Labeler Name | Apotex Corp |
| Pharmaceutical Class | Tetracycline-class Antibacterial [EPC], Tetracyclines [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA204439 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 60505-6098-01 (60505609801)
| NDC Package Code | 60505-6098-1 |
|---|---|
| Billing NDC | 60505609801 |
| Package | 10 VIAL, SINGLE-USE in 1 CARTON (60505-6098-1) / 5 mL in 1 VIAL, SINGLE-USE |
| Marketing Start Date | 2019-04-09 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |